Global CD40 Ligand Market Research Report 2012-2024

July 2019 | 103 pages | ID: G9C041C8B97EN
HeyReport

Abstracts

SUMMARY


The global CD40 Ligand market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

• ISF-35
• LOAd-700
• MEDI-4920
• MegaCD40L
• Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

• Biogen, Inc.
• Bristol-Myers Squibb Company
• eTheRNA Immunotherapies NV
• ImmuNext, Inc.
• Juno Therapeutics Inc.
• MedImmune, LLC
• Targovax AS
• XL-protein GmbH

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

• Hepatitis B
• Bladder Cancer
• Liver Cancer
• Ovarian Cancer
• Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 ISF-35
    1.2.1.2 LOAd-700
    1.2.1.3 MEDI-4920
    1.2.1.4 MegaCD40L
    1.2.1.5 Others
  1.2.2 by Application
    1.2.2.1 Hepatitis B
    1.2.2.2 Bladder Cancer
    1.2.2.3 Liver Cancer
    1.2.2.4 Ovarian Cancer
    1.2.2.5 Others
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 ISF-35 Market, 2013-2018
  4.1.2 LOAd-700 Market, 2013-2018
  4.1.3 MEDI-4920 Market, 2013-2018
  4.1.4 MegaCD40L Market, 2013-2018
  4.1.5 Others Market, 2013-2018
4.2 Market Forecast
  4.2.1 ISF-35 Market Forecast, 2019-2024
  4.2.2 LOAd-700 Market Forecast, 2019-2024
  4.2.3 MEDI-4920 Market Forecast, 2019-2024
  4.2.4 MegaCD40L Market Forecast, 2019-2024
  4.2.5 Others Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Hepatitis B Market, 2013-2018
  5.1.2 Bladder Cancer Market, 2013-2018
  5.1.3 Liver Cancer Market, 2013-2018
  5.1.4 Ovarian Cancer Market, 2013-2018
  5.1.5 Others Market, 2013-2018
5.2 Market Forecast
  5.2.1 Hepatitis B Market Forecast, 2019-2024
  5.2.2 Bladder Cancer Market Forecast, 2019-2024
  5.2.3 Liver Cancer Market Forecast, 2019-2024
  5.2.4 Ovarian Cancer Market Forecast, 2019-2024
  5.2.5 Others Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Biogen, Inc.
8.2 Bristol-Myers Squibb Company
8.3 eTheRNA Immunotherapies NV
8.4 ImmuNext, Inc.
8.5 Juno Therapeutics Inc.
8.6 MedImmune, LLC
8.7 Targovax AS
8.8 XL-protein GmbH

9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Specifications of CD40 Ligand
Table Products Segment of CD40 Ligand
Table ISF-35 Overview
Table LOAd-700 Overview
Table MEDI-4920 Overview
Table MegaCD40L Overview
Table Others Overview
Table Global CD40 Ligand Market by Type, 2011-2022 (USD Million)
Table Application Segment of CD40 Ligand
Table Hepatitis B Overview
Table Bladder Cancer Overview
Table Liver Cancer Overview
Table Ovarian Cancer Overview
Table Others Overview
Table Global CD40 Ligand Market by Application, 2011-2022 (USD Million)
Table Global CD40 Ligand Market by Region, 2011-2022 (USD Million)
Table Cost of CD40 Ligand
Table Market Dynamics
Table Policy of CD40 Ligand
Table GDP of Major Countries
Table ISF-35 CAGR by Revenue and Volume, 2012-2018
Table LOAd-700 CAGR by Revenue and Volume, 2012-2018
Table MEDI-4920 CAGR by Revenue and Volume, 2012-2018
Table MegaCD40L CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table ISF-35 CAGR by Revenue and Volume, 2012-2024
Table LOAd-700 CAGR by Revenue and Volume, 2012-2024
Table MEDI-4920 CAGR by Revenue and Volume, 2012-2024
Table MegaCD40L CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hepatitis B CAGR by Revenue and Volume, 2012-2018
Table Bladder Cancer CAGR by Revenue and Volume, 2012-2018
Table Liver Cancer CAGR by Revenue and Volume, 2012-2018
Table Ovarian Cancer CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global CD40 Ligand Market by Vendors, 2012-2018 (USD Million)
Table Global CD40 Ligand Market by Vendors, 2012-2018 (in Volume)
Table Global CD40 Ligand Market Share by Vendors, 2012-2018 (USD Million)
Table Global CD40 Ligand Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Biogen, Inc. Profile List
Table Microecological Modulator Operating Data of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table eTheRNA Immunotherapies NV Profile List
Table Microecological Modulator Operating Data of eTheRNA Immunotherapies NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ImmuNext, Inc. Profile List
Table Microecological Modulator Operating Data of ImmuNext, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Juno Therapeutics Inc. Profile List
Table Microecological Modulator Operating Data of Juno Therapeutics Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Profile List
Table Microecological Modulator Operating Data of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Targovax AS Profile List
Table Microecological Modulator Operating Data of Targovax AS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table XL-protein GmbH Profile List
Table Microecological Modulator Operating Data of XL-protein GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure CD40 Ligand Picture
Figure Industry Chain Structure of CD40 Ligand
Figure SWOT of CD40 Ligand
Figure ISF-35 Market Size and Growth, 2012-2018 (USD Million)
Figure ISF-35 Market Size and Growth, 2012-2018 (in Volume)
Figure LOAd-700 Market Size and Growth, 2012-2018 (USD Million)
Figure LOAd-700 Market Size and Growth, 2012-2018 (in Volume)
Figure MEDI-4920 Market Size and Growth, 2012-2018 (USD Million)
Figure MEDI-4920 Market Size and Growth, 2012-2018 (in Volume)
Figure MegaCD40L Market Size and Growth, 2012-2018 (USD Million)
Figure MegaCD40L Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure ISF-35 Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure ISF-35 Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure LOAd-700 Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure LOAd-700 Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure MEDI-4920 Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure MEDI-4920 Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure MegaCD40L Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure MegaCD40L Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hepatitis B Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Bladder Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Liver Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Ovarian Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure CD40 Ligand Market Concentration by Region
Figure Marketing Channels Overview